Charles C. Wykoff

Charles C. Wykoff

Charles C. Wykoff, MD, PhD is a prominent international medical and surgical vitreoretinal specialist and a leading clinician scientist. He is passionate about translational research, clinical trial design, and accelerating drug-development programs. He serves on multiple scientific and medical advisory boards, safety monitoring committees, and global steering committees for endeavors spanning the innovative process from early to late-stage developments. His guiding philosophy is to build and strengthen innovative, ethical teams focused on developing new approaches to improving outcomes for blinding diseases.

Dr. Wykoff is Director of Research at Retina Consultants of Texas; Chairman of Research & Clinical Trials, Retina Consultants of America; and Deputy Chair of Ophthalmology for the Blanton Eye Institute, Houston Methodist Hospital.

He received his baccalaureate from MIT, PhD from Oxford University while being recognized as a Marshall Scholar, and MD from Harvard Medical School. Dr. Wykoff completed ophthalmology residency and vitreoretinal fellowship at Bascom Palmer Eye Institute where he served as Chief Resident & Co-Director of Ocular Trauma and received a Heed Fellowship and the Ronald G. Michels Award.

He has published over 200 peer-reviewed manuscripts and frequently speaks at national and international academic meetings. He is President of the Vit-Buckle Society (2021-2023), serves on the ASRS Board of Directors, is a founding member of the Ophthalmology Retina Editorial Board, and is the Chief Medical Editor for Retina Specialist. He has been awarded multiple Achievement, Honor and Senior Honor Awards including the ASRS Young Investigator and the AAO Secretariat Awards.